Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Get Free Report) insider Mark Sabag sold 62,102 shares of Teva Pharmaceutical Industries stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $30.14, for a total transaction of $1,871,754.28. Following the completion of the sale, the insider directly owned […]

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) General Counsel Bryan Wahl sold 4,125 shares of the stock in a transaction on Wednesday, March 18th. The shares were sold at an average price of $68.71, for a total value of $283,428.75. Following the completion of the sale, the general counsel owned 68,190 shares of the […]

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) EVP Elizabeth Hougen sold 215,048 shares of Ionis Pharmaceuticals stock in a transaction on Monday, March 16th. The stock was sold at an average price of $72.40, for a total transaction of $15,569,475.20. Following the completion of the sale, the executive vice president owned 92,832 shares of […]

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) COO Peter Radovich sold 16,515 shares of Mirum Pharmaceuticals stock in a transaction dated Monday, March 16th. The stock was sold at an average price of $91.98, for a total value of $1,519,049.70. Following the sale, the chief operating officer directly owned 40,272 shares in the company, […]

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Get Free Report) CEO Jack Khattar sold 35,000 shares of the company’s stock in a transaction dated Friday, March 13th. The shares were sold at an average price of $50.37, for a total value of $1,762,950.00. Following the completion of the sale, the chief executive officer owned 958,100 shares in […]

Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Free Report) CEO Ian Mortimer sold 7,308 shares of the stock in a transaction dated Friday, March 13th. The stock was sold at an average price of $55.23, for a total transaction of $403,620.84. Following the completion of the sale, the chief executive officer directly owned 19,923 shares in […]

Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Free Report) insider Christopher John Kenney sold 1,410 shares of the company’s stock in a transaction dated Friday, March 13th. The shares were sold at an average price of $55.23, for a total value of $77,874.30. Following the completion of the sale, the insider directly owned 7,069 shares of […]

Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Free Report) insider Christopher John Kenney sold 1,410 shares of the firm’s stock in a transaction on Friday, March 13th. The shares were sold at an average price of $55.23, for a total transaction of $77,874.30. Following the completion of the transaction, the insider directly owned 7,069 shares of […]

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Free Report) insider Christopher Mutz sold 3,162 shares of the business’s stock in a transaction dated Friday, March 13th. The shares were sold at an average price of $71.64, for a total value of $226,525.68. Following the completion of the sale, the insider owned 91,309 shares in the company, […]

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) insider Krishnan Viswanadhan sold 2,959 shares of the stock in a transaction on Thursday, March 5th. The shares were sold at an average price of $27.80, for a total transaction of $82,260.20. Following the completion of the sale, the insider directly owned 5,141 shares of the company’s […]

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Get Free Report) EVP Christine Fox sold 7,924 shares of the business’s stock in a transaction on Thursday, March 5th. The shares were sold at an average price of $31.67, for a total transaction of $250,953.08. Following the sale, the executive vice president directly owned 84,905 shares of the […]

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Get Free Report) CEO Richard Francis sold 20,025 shares of the company’s stock in a transaction on Thursday, March 5th. The shares were sold at an average price of $31.67, for a total value of $634,191.75. Following the completion of the sale, the chief executive officer owned 1,170,639 shares […]

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Free Report) General Counsel Shannon Kelley sold 360 shares of the business’s stock in a transaction dated Friday, March 6th. The shares were sold at an average price of $431.94, for a total value of $155,498.40. Following the completion of the transaction, the general counsel owned 12,138 shares in […]

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Free Report) CEO William John Sibold sold 1,663 shares of Madrigal Pharmaceuticals stock in a transaction dated Friday, March 6th. The stock was sold at an average price of $431.94, for a total value of $718,316.22. Following the transaction, the chief executive officer owned 161,829 shares of the company’s […]